CDRH’s Mansfield Addresses Upcoming Drug/Dx Co-Development Guidance
This article was originally published in The Gray Sheet
Executive Summary
Either an IND or an IDE will be sufficient for companion diagnostic studies, a CDRH diagnostics official clarified last week. That is among the issues that will be addressed in an upcoming co-development draft guidance.